A multiomic analysis led by the IrsiCaixa AIDS Research Institute has uncovered genetic and immune mechanisms in some ...

Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...

This advertisement has not loaded yet, but your article continues below. Some MPs think recent Liberal success in New Brunswick shows the party's brand still holds appeal with voters 'Prior to ...

PrEP use increased between 2013 and 2023, according to a research letter published online in the Journal of the American Medical Association.

Long-acting injectable PrEP is now to be covered without cost-sharing under Affordable Care Act rules, the Biden ...

With just 15 days until the presidential election, the federal government is proposing new rules that aim to bolster ...

Sep. 25, 2024 — Almost everyone knows about HIV. Fewer people know about its relative, HTLV-1. However, HTLV-1 can cause serious illnesses, including cancer. To develop ways to combat this virus ...

co-chairs of the African-led HIV Control Working Group. Doxycycline post-exposure prophylaxis increases tetracycline resistance genes in the gut, without significantly affecting microbiome ...

The measure waives the need for a primary care physician’s prescription for HIV medications like PrEP and Doxy PEP.

Human immunodeficiency virus (HIV) is a condition that attacks a person's immune system. The immune system helps identify and destroy pathogens that cause infection and illness in the body. The risk ...

Viatris, a manufacturer of generic antiretroviral HIV drugs and hormonal contraceptives ... promising preclinical and clinical results for on-demand topical pre- or post-exposure HIV prevention.

The data from 31 presentations across HIV treatment and prevention ... data will include an analysis of newly initiated pre-exposure prophylaxis (PrEP) use in priority populations with unmet ...